Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Cincinnati Biotech Firm Moving HQ to Indiana

Abstract:
PDS Biotechnology Corporation, a developer of disease-destroying nanotechnology, announced today it will relocate its Cincinnati headquarters and laboratory here with the help of a $2 million grant from the state's 21st Century Research and Technology fund.

Cincinnati Biotech Firm Moving HQ to Indiana

INDIANAPOLIS, IN | Posted on January 21st, 2009

The biopharmaceutical company, which will locate its operations at a yet-to-be announced site in the capitol city, will bring to Indiana its Versamune™ platform technology that allows scientists to deliver targeted nanoparticles to the body's immune system and then stimulate the immune system to destroy infections and cancers.

"The 21st Century Fund provides critical seed capital to emerging high-growth companies such as PDS Biotechnology that are necessary to ensure our state's economic growth," said Governor Mitch Daniels.

PDS Biotech's technology, which has already garnered financial support from the U.S. National Cancer Institute, will first appear in a therapy the company is developing aimed at combating currently incurable cancers associated with the human papilloma virus (HPV). Toxicology studies are underway now for the cancer-combating technology, and company officials plan to begin clinical trials in the next 18 months.

"This is a very exciting time for the company. The VersamuneTM technology has demonstrated the potential to overcome the key efficacy and safety obstacles associated with other leading technologies. PDS Biotechnology chose to locate the company in Indiana over other competing states based on several important factors including the presence of top-rated universities, a world-class nanotechnology center and the solid and rapidly growing biotechnology infrastructure," said Dr. Frank Bedu-Addo, president and chief executive officer of PDS Biotechnology Corporation.

The development of the therapy represents a breakthrough for treating HPV-related cancers. The virus is the most prevalent sexually transmitted agent worldwide and is present in nearly all cases of cervical cancer - the second leading cause of death in women worldwide.

The news of PDS relocating to Indiana comes less than three months after the U.S. National Cancer Institute's Nanotechnology Characterization Lab (NCL) announced it will collaborate with the firm to complete preclinical development of its HPV-cancer combating therapy. The NCL, a collaboration between the U.S. National Cancer Institute, the U.S. Food and Drug Administration and the National Institute of Standards and Technologies, will assist PDS Biotechnology in performing selected physical, chemical and biological studies to help speed the technology through regulatory submissions with the FDA.

PDS Biotech is one of 63 businesses awarded a 21st Century Fund grant since January 2006.

####

About Biotechnology Corporation
PDS Biotechnology Corporation is a biopharmaceutical company pioneering the development of safe, simple, potent and targeted immunotherapies for the treatment of cancer and infectious diseases. Unlike typical cancer and antiviral immunotherapies, the patented nanoparticle VersamuneTM technology both facilitates the uptake of disease-associated proteins and peptides by the cells of the immune system and simultaneously activates the immune system to generate a strong and specific immune response against the infected cells in the body, resulting in eradication of the cancer or viral disease.

About IEDC
Created by Governor Mitch Daniels in 2005 to replace the former Department of Commerce, the Indiana Economic Development Corporation is governed by a 12-member board chaired by Governor Daniels. Indiana Secretary of Commerce Mitch Roob serves as the chief executive officer of the IEDC. For more information about IEDC, visit www.iedc.in.gov.

For more information, please click here

Copyright © PDS Biotechnology Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Animal study shows flexible, dissolvable silicon device promising for brain monitoring: Other applications include post-operative observation for vascular, cardiac, and orthopaedic procedures, finds Penn study May 5th, 2016

Speedy ion conduction in solid electrolytes clears road for advanced energy devices May 5th, 2016

Engineers create a better way to boil water -- with industrial, electronics applications May 5th, 2016

Clues on the path to a new lithium battery technology: Charging produces highly reactive singlet oxygen in lithium air batteries May 5th, 2016

Openings/New facilities/Groundbreaking/Expansion

SUNY Poly Partnership with Japan's New Energy and Industrial Development Organization Drives Investment in and Installation of Emerging ‘Green’ Technologies at World-Class 'Zero Energy Nano' Building March 22nd, 2016

Composite Pipe Long Term Testing Facility February 10th, 2016

SUNY Poly and GLOBALFOUNDRIES Announce New $500M R&D Program in Albany To Accelerate Next Generation Chip Technology: Arrival of Second Cutting Edge EUV Lithography Tool Launches New Patterning Center That Will Generate Over 100 New High Tech Jobs at SUNY Poly February 9th, 2016

SUNY Poly Welcomes DPS as the Global Engineering Firm Opens Its U.S. Advanced Technology Group Headquarters at Cutting-Edge ZEN Building November 20th, 2015

Nanomedicine

Animal study shows flexible, dissolvable silicon device promising for brain monitoring: Other applications include post-operative observation for vascular, cardiac, and orthopaedic procedures, finds Penn study May 5th, 2016

Unique nano-capsules promise the targeted drug delivery: Russian scientists created unique nano-capsules for the targeted drug delivery May 5th, 2016

The intermediates in a chemical reaction photographed 'red-handed' Researchers at the UPV/EHU-University of the Basque Country have for the first time succeeded in imaging all the steps in a complex organic reaction and have resolved the mechanisms that explain it May 4th, 2016

Nuclear pores captured on film: Using an ultra fast-scanning atomic force microscope, researchers from the University of Basel have filmed 'living' nuclear pore complexes at work for the first time May 3rd, 2016

Announcements

Speedy ion conduction in solid electrolytes clears road for advanced energy devices May 5th, 2016

Engineers create a better way to boil water -- with industrial, electronics applications May 5th, 2016

Clues on the path to a new lithium battery technology: Charging produces highly reactive singlet oxygen in lithium air batteries May 5th, 2016

Unique nano-capsules promise the targeted drug delivery: Russian scientists created unique nano-capsules for the targeted drug delivery May 5th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic